Bain Capital (BCSF) announced that it has reached an agreement with Ageas (AGESY) to sell esure. The proposed transaction is fully aligned with Ageas’s strategic priorities for M&A in Europe under Elevate27. “It increases Ageas’s European markets presence through the acquisition of a controlled entity, reinforces its positioning in the UK, generates shareholder value from the realization of synergies and enhances the cash generation of the Group,” the company said. Under the terms of the transaction, Ageas will pay Bain Capital a cash consideration of GBP 1.295 billion for esure. The completion of the transaction is expected to occur in 2H 2025 and remains subject to regulatory approvals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCSF:
- Bain Capital Specialty Finance price target lowered to $17 from $18 at Keefe Bruyette
- Bain’s Virgin Australia to meet with investors to relist on ASX, Reuters says
- Bain, WPP plan to break up Kantar, FT reports
- Bain Capital Specialty Finance price target raised to $18 from $17 at Keefe Bruyette
- Bain Capital Specialty Finance Reports Strong Earnings Call